Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Another one trick pony just like motif bio. Was 20p once.
Another one trick pony just like motif bio. Was 20p once.
i thought new CEO was a marketing expert - why get her in if to utilise her skills?
Hospitals and clinics is an obvious route but not sure a marketing expert has an specific connections to exploit there.
Time will tell
Talking to Adam Reynolds they're not going down the marketing route. Sounds like they'll be using Penny and Lyn's expertise and connections to get the product into similar places as Yourgene. Hospitals & Clinics. America & Asia were mentioned.
the product is great, however, the marketing to date has been terrible. New CEO seems to be exactly what the company needs at this point in time.
However, the big issue is where will a marketing budget come from? I'm sure new CEO will be coming up with a cost effective marketing plan but it will still need money.
With less than £100k rev for H1 I think most of last placing money will have already been spent.
I reckon we will get a positive RNS soon and then a placing soon after.
Personally I think it's a very positive move. I think that although Matthew certainly moved the product forward and did negotiate some good agreements I think the board didn't feel he had quite enough about him to really drive the product forward and create a powerful brand . At the end of the day all the development has been done, it's been proved it works it just needs aggressively marketing to start generating some real sales. Penny's credentials suggest she has the skills and experience to do this and really release mylotus's potential and I think the board have signalled their intention by appointing her.
Does feel like a revolving door ... difficult to get traction and let somebody make their mark. Its just another factor to this share that just keeps you guessing! Walls talked a good game, said he was changing to his plan blah blah. Oh well onwards and upwards ... lets see if Penny can make us a few Quid : )
Surprising the speed one CEO goes and a new CEO comes in - was Walls pushed or did he organise his replacement ?
It certainly sounds like she has the creds. Let's see if she can walk the walk.